Audiologists in Chambersburg, PA Accepting Medicare

8 Audiologists found. Showing 1 - 8

Easter Seals Central Pa Audiologist Medicare: Not Enrolled in Medicare Practice Location: 55 Hamilton Rd, Chambersburg, PA 17201 Phone: 717-264-1539

Keystone Rural Health Center Audiologist Medicare: Not Enrolled in Medicare Practice Location: 111 Chambers Hill Dr Ste 101, Chambersburg, PA 17201 Phone: 717-709-7997    Fax: 717-261-4725

Kristin Jones, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 22 St Paul Dr Ste 202, Chambersburg, PA 17201 Phone: 717-217-6870    Fax: 717-217-6945

Kaitlyn Dawes, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 22 St Paul Dr, Chambersburg, PA 17201 Phone: 717-217-6870

Melissa Leigh Kohler, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 111 Chambers Hill Dr Ste 101, Chambersburg, PA 17201 Phone: 717-709-7997

Barry L Deese, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 755 Norland Ave, Suite 202, Chambersburg, PA 17201 Phone: 717-217-6870    Fax: 717-217-6945

Ms. Christine Kay Lindeman, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 755 Norland Avenue, Suite 202, Chambersburg, PA 17201 Phone: 717-217-6870    Fax: 717-217-6945

Dgn Ventures Audiologist Medicare: Not Enrolled in Medicare Practice Location: 166 S Main St Ste 3, Chambersburg, PA 17201 Phone: 717-504-5229

News Archive

Metabolite in gut microbiome could improve outcomes after bone marrow transplant

Could playing better defense make bone marrow transplants more successful? With this question in mind, researchers began looking at whether the trillions of little bugs and bacteria living in our gastrointestinal tract could be the key to playing defense.

Icagen, Pfizer commence Nav1.7 Phase I clinical studies for pain and related disorders

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders, which is being conducted in collaboration with Pfizer. As previously reported, the companies recently selected a candidate compound to advance into further clinical studies. Dosing of this candidate compound has now been initiated in a Phase I study in healthy volunteers.

Study reveals how Seneca Valley Virus interacts with tumor receptors

Seneca Valley Virus sounds like the last bug you'd want to catch, but it could be the next breakthrough cancer therapy.

Inhibiting TRPV4 protects against diet-induced obesity, inflammation and insulin resistance

Ember Therapeutics, Inc., a company harnessing breakthroughs in brown fat biology and insulin sensitization to revolutionize the treatment of metabolic disease, today announced the publication of key preclinical data demonstrating that inhibition of the Transient Receptor Potential Vanilloid (TRPV) family of ion channels - specifically TRPV4 - resulted in activation of brown/beige fat and protection from diet-induced obesity, inflammation and insulin resistance. Ember holds an exclusive option to license these TRPV4 findings and technology.

Read more Medical News

› Verified 7 days ago